Two independent lines of evidence support this (1) ANXA1 levels are elevated in both patients and mice with T2D and (2) tissue levels of ANXA1 are decreased in HFD-fed mice (Figure 1) suggesting it has been released from intracellular stores. The gene discussed is ANXA1; the disease is type 2 diabetes mellitus.